Clinical Trial Update: Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). [Phase 2]

View source ↗

Summary

A Phase 2 BARON trial evaluating bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma has completed, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Olfactory Neuroblastoma

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Olfactory Neuroblastoma, Esthesioneuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2025-08-08